Clinical and Research Expertise - Discovered the hereditary kidney cancer gene TRC8 and its function, raising the potential for new treatment strategies
- Discovered the AML1-ETO fusion due to the 8;21 chromosome translocation in acute myeloid leukemia
- Board certified in medical oncology and internal medicine
- Former Director, DNA Sequencing Core,University of Colorado Cancer Center
- Former Co-Director,Hematology/Medical Oncology Fellowship Training, University of Colorado Cancer Center
Special Interests - Metastatic kidney cancer
- Hereditary kidney cancer
- Molecular biology of chromosome alterations in cancer
- Oncogenes and tumor suppressor genes
MUSC Kidney Cancer Care - Dedicated weekly renal cell cancer clinicat MUSC Hollings Cancer Center
- Involvement in diverse cooperative group and industry sponsored clinical trials
- Multidisciplinary care coordinated with urology specialists
- Major clinical and basic/translational research program under development (based on successful Colorado clinic) and envisioned as the Southeast’s primary referral center for renal cancer
| 
